Mgr. Dominika Škrnová

Technician, Michal Šmída Research Group

correspondence Address:
Kamenice 753/5, 625 00 Brno

e‑mail:

Basic information

Type

Total number of publications: 3

2023

CRISPR/Cas9 technology as a useful tool in the study of chornic lymphocytic leukemia.

PESCHELOVÁ Helena MANČÍKOVÁ Veronika DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika HEJRET Václav ŠMÍDA Michal

Conference abstract

Year: 2023, type: Conference abstract
CRISPR/Cas9 technology as a useful tool in the study of chronic lymphocytic leukemia.

PESCHELOVÁ Helena KOZLOVÁ Veronika MANČÍKOVÁ Veronika DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika HEJRET Václav ŠMÍDA Michal

Conference abstract

Year: 2023, type: Conference abstract

2022

Combined drug and CRISPR/CAS9 screening reveals specific targets for SF3B1- and NOTCH1- mutated CLL cells.

DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika GOTTUMUKKALA Narendra Varma LODHI Yusuf ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract